T-lymphoblastic lymphoma, the survival time is mainly related to the severity of the disease and the treatment. The survival rate depends on whether the patient is treated with standardized therapy and whether he/she is sensitive to chemotherapeutic agents. T-lymphoblastic lymphoma is a highly aggressive malignant tumor with rapid onset and progression, and without aggressive treatment, the 5-year survival rate is generally no more than 10%. With appropriate treatment, the 5-year survival rate is generally around 50%, and 80-90% in children. The mainstay of treatment for T-lymphoblastic lymphoma is chemotherapy. Targeted therapy may also be used, and stem cell transplantation is preferred when available. However, all of the above treatments need to be carried out under the supervision of a doctor. After the diagnosis of T-lymphoblastic lymphoma is confirmed, it is recommended to have regular treatment and regular chemotherapy, especially for children and young patients.